NURS FPX 9030 Assessment 2 Data and Data Analysis
Student Name
Capella University
NURS-FPX9030: Doctor of Nursing Practice Across the Lifespan III
Professor Name
Submission Date
Introduction
Diabetes mellitus is still one of the most common chronic diseases faced by patients during visits to primary care facilities. Over the last year at the project site, several patients did not achieve good control of diabetes, as evidenced by having 42% of patients with an A1c greater than 9% and only 36% of patients having an A1C less than 7 percent (Chief Nursing Officer, Personal Communication, October 10th, 2020). The percentages are much higher in comparison with national standards of diabetes management because they are around 22 percent of adults with diabetes with poor glycemic control and about 50 percent of them with A1C goals (Adjei et al., 2020; Chief Nursing Officer, Personal Communication, October 10th, 2020). The absence of a standardized, protocolized course of follow-up, with the possibility to at least receive education on diabetes, led to patients not receiving adequate education at all, and missing follow-up opportunities and less than optimal outcomes. To fill the gaps, a quality improvement (QI) initiative was carried out based on the following PICOT question: Among nursing personnel working with adult patients with diabetes (P), the introduction of the ADA diabetes follow-up protocol (I) in comparison with the current practice (C) in terms of its effects on glycemic control (O) in 8 weeks (T)? An eight-week project adopted an American Diabetes Association (ADA) diabetes follow-up protocol and assessed the effects of the protocol on the glycemic outcomes, clinical competency of staff, staff adherence to follow-up, and self-management behaviors in patients. The project design, data collection methods, statistical studies, and findings are reflected in the paper, and the evidence to prove that structured, evidence-based ADA follow-up protocols may lead to clinically significant outcomes in glycemic control is provided.
Project Design and Data Collection
The pre-post design was utilized by the project team to acquire baseline and post-intervention data of the 20 adult participants and 8 nurses who are enrolled in the project. Before the project started, IRB approval was taken care of, and necessary Health Insurance Portability and Accountability Act (HIPAA) compliance was established; to maintain anonymity, the names of all participants were substituted with coded ones. The pre-post project design is a frequently employed technique within quality improvement tests to analyze the data and accomplishments of well-organized clinical measures. It is based on a pre-post design framework to be an effective measure of the impact of structured intervention on achieving success in real-life healthcare environments (Mitchell et al., 2025). To yield a valid and reliable measure of clinical outcomes, data collection tools adopted in a quality improvement project need to be valid and reliable to generate an accurate measure of clinical outcomes (Kaplan et al., 2021). Discussing all data collection tools, their content validity was verified as strong, considering evaluation by experts and further consistent use of the same procedures to collect data during the project, which lasted eight weeks.
Data Analysis
The results obtained at the 8-week follow-up time on the quantitative outcomes were measured using both descriptive statistics to determine the impact of the ADA diabetes follow-up protocol on the glycemic results, the competence of the staff, and the self-management behaviors of the staff. Since there was a need to compare baseline vs. week 8 HbA1c values of the participants, the primary inferential statistics were t-tests to compare the mean differences of one group at two different times. Descriptive statistics (percentage) were produced to sum up the adherence rates to follow up, competency scores of the staff, and the checklist results of self-management. The projects of quality improvement need to be analyzed statistically in order that the team can understand whether the changes in observed outcomes are significant changes in clinical outcomes or mere accidents of chance (Mangory et al., 2021). Moreover, repeated measures (pre and post) can be performed using the same group of participants, which increases the sensitivity of the statistic and sluces individual variability (Chicco et al., 2025). All analyses were performed on de-identified data obtained in the EMR of the clinic and the standardized assessment tools; as a result, all analyses were done in summary tables to be easily interpreted.
Project Results
All outcome measures improved among the participants who joined the project compared to the measurements of outcomes at baseline. As an example, the mean HbA1c fell 1.52 percentage points (9.95 per cent to 8.22 per cent) in 8 weeks. The respondents who responded were extremely involved in utilizing the structured protocol given to them, according to the follow-up completion rate of 89.2. Following training, 7 of 8 (87.5%) of the nursing staff scored within the 80 percent competency range, with an average score of 59.0 percent before the training and 85.4 percent after training. The mean self-management engagement scores of those who attended week 8 were 7.4 out of 10, with 70% of those attending the week 8 fully compliant with the medications, 65% of those attending the week 8 regularly completing the daily monitoring of blood sugar levels. On the whole, the findings suggest general positive changes concerning the clinical outcome, operational outcome, and behavioral outcome domains of the participants who participated in the project. Tables 1 to 6 in Appendix A contain the results.
Project Outcomes
The project results evidence suggests that the application of the follow-up protocol offered by the American Diabetes Association (ADA) turned out to be effective in reaching meaningful changes in glycemic control, thus addressing the PICOT question. The resultant HbA1c mean decrease of 1.52 points surpassed the set criteria of success of 0.5 points and was clinically significant. Nonetheless, merely 10% of study participants had reached the target HbA1c (<7%); despite significant improvement observed after 8 weeks of intervention, it is likely that the full target would also need a more extended intervention. Participants had 67% of planned visits delivered because of transportation: this led to adverse glycemic patterns; ubiquitous barriers and transportation issues were other unanticipated results. Continuous improvement quality initiatives aimed at chronic disease management always reveal that organized, researched procedures result in measurable improvement (Endalamaw et al., 2024). Continuous tracking, adjustment intervention, and follow-up of at least 1 year of outpatient glycemic measurement patterns are necessary to make sure that the benefit provided by outpatient glycemic improvement programs is sustainable (Jahed et al., 2025). The project strengths were a high level of staff competency, a high level of follow-up adherence, and proper EHR documentation. Limitations were also associated with the short (8-week) length of intervention time; the results might not be applied to other groups of adults with diabetes in wider community-based clinical environments.
Conclusion
An 8-week trial on the use of the ADA diabetes follow-up protocol demonstrated that the use of the intervention resulted in substantial clinical outcomes in terms of glycemic control, increase in staff competency, compliance with follow-up, and self-management behaviour in adults with type II diabetes in a nurse-led primary care infrastructure. Even despite the still some limitations observed in the attainment of full glycemic target levels, the participants were only followed over a period of time. The results all indicate that promoting and enforcing standard evidence-based procedures of diabetes follow-up will result in increased success in enhancing the outcome of chronic diseases within the outpatient primary care environment through the application of a continuous process.
Step By Step Instructions To Write
NURS FPX 9030 Assessment 2
Contact us today and receive expert step-by-step instructions for NURS FPX 9030 Assessment 2.
Instructions File For
NURS FPX 9030 Assessment 2
Contact us to get the instruction file.
Scoring Guide for
NURS FPX 9030 Assessment 2
Contact us to get the scoring guide.
References in APA Format For
NURS FPX 9030 Assessment 2
Below are the references used in NURS FPX 9030 Assessment 2 Data and Data Analysis:
Adjei, S. K., Adjei, P., & Nkrumah, P. A. (2025). Poor glycemic control and its predictors among type 2 diabetes patients: Insights from a single‐center retrospective study in Ghana. Health Science Reports, 8(3), 8–12. https://doi.org/10.1002/hsr2.70558
Chicco, D., Sichenze, A., & Jurman, G. (2025). A simple guide to the use of Student’s t-test, Mann-Whitney U test, Chi-squared test, and Kruskal-Wallis test in biostatistics. BioData Mining, 18(1), e56. https://doi.org/10.1186/s13040-025-00465-6
Endalamaw, A., Khatri, R. B., Mengistu, T. S., Erku, D., Wolka, E., Zewdie, A., & Assefa, Y. (2024). A scoping review of continuous quality improvement in healthcare system: Conceptualization, models and tools, barriers and facilitators, and impact. BioMed Central Health Services Research, 24(1), e487. https://doi.org/10.1186/s12913-024-10828-0
Kaplan, R. S., Jehi, L., Ko, C. Y., Pusic, A., & Witkowski, M. (2021). Health Care Measurements that Improve Patient Outcomes. NEJM Catalyst, 2(2). https://doi.org/10.1056/cat.20.0527
Mangory, K. Y., Ali, L. Y., Rø, K. I., & Tyssen, R. (2021). Effect of burnout among physicians on observed adverse patient outcomes: a literature review. BMC Health Services Research, 21(1). https://doi.org/10.1186/s12913-021-06371-x
Mitchell, S., Schmitz, F. M., Janusz Janczukowicz, Buzzi, A.-L., Haas, N., Hitzblech, T., Wagenfuehr, J., Idris Guessous, & Guttormsen, S. (2025). Does Education Design Matter? Evaluating an Evidence-Based Continuing Education Intervention on Genomic Testing for Primary Care; a Pre-Test Post-Test Study. Journal of CME, 14(1). https://doi.org/10.1080/28338073.2025.2526234
Jahed, S. A., Nikoosokhan, A., Moravej, H., Sarkheil, P., Malek, M., Esteghamati, A., Hosseinpanah, F., & Sedaghat, S. (2025). The use of continuous glucose monitoring in outpatient diabetes care: Iranian expert consensus statement. Diabetes Research and Clinical Practice, 230, e112961. https://doi.org/10.1016/j.diabres.2025.112961
Tables Data For
NURS FPX 9030 Assessment 2
Table 1
Demographic Characteristics and Baseline HbA1c (N = 20)
Participant ID | Age Group | Sex | Race/Ethnicity | Insurance Type | T2DM Duration (yrs) | Baseline HbA1c (%) |
P001 | 45–54 | Female | Hispanic/Latino | Medicaid | 6 | 9.8 |
P002 | 55–64 | Male | Black/African American | Medicare | 11 | 10.2 |
P003 | 35–44 | Female | White/Non-Hispanic | Private | 3 | 8.7 |
P004 | 55–64 | Female | Hispanic/Latino | Medicaid | 9 | 11.1 |
P005 | 45–54 | Male | Asian | Medicaid | 5 | 9.4 |
P006 | 65+ | Male | Black/African American | Medicare | 14 | 10.8 |
P007 | 35–44 | Female | White/Non-Hispanic | Private | 2 | 8.3 |
P008 | 55–64 | Male | Hispanic/Latino | Medicaid | 8 | 9.9 |
P009 | 45–54 | Female | Asian | Private | 4 | 8.9 |
P010 | 65+ | Female | Black/African American | Medicare | 16 | 11.4 |
P011 | 35–44 | Male | White/Non-Hispanic | Private | 3 | 8.5 |
P012 | 55–64 | Female | Hispanic/Latino | Medicaid | 10 | 10.6 |
P013 | 45–54 | Male | Black/African American | Medicaid | 7 | 9.7 |
P014 | 65+ | Female | Hispanic/Latino | Medicare | 13 | 10.9 |
P015 | 35–44 | Male | Asian | Private | 2 | 8.2 |
P016 | 55–64 | Female | White/Non-Hispanic | Private | 9 | 9.3 |
P017 | 45–54 | Male | Hispanic/Latino | Medicaid | 6 | 10.1 |
P018 | 65+ | Female | Black/African American | Medicare | 18 | 11.7 |
P019 | 35–44 | Female | Asian | Private | 1 | 7.8 |
P020 | 55–64 | Male | White/Non-Hispanic | Private | 11 | 9.6 |
Note. All patient identifiers have been replaced with project codes. Age group, sex, race/ethnicity, and insurance type were self-reported. T2DM duration and baseline HbA1c were extracted from EHR records at Week 1. T2DM = type 2 diabetes mellitus; HbA1c = hemoglobin A1c.
Table 2
HbA1c Outcomes Across Measurement Time Points (N = 20)
Participant ID | Baseline HbA1c (%) | Week 4 HbA1c (%) | Week 8 HbA1c (%) | Change (Baseline to Wk 8) | Target Met (<7%) |
P001 | 9.8 | 9.1 | 8.4 | −1.4 | No |
P002 | 10.2 | 9.6 | 8.8 | −1.4 | No |
P003 | 8.7 | 8.1 | 7.4 | −1.3 | No |
P004 | 11.1 | 10.3 | 9.2 | −1.9 | No |
P005 | 9.4 | 8.7 | 7.9 | −1.5 | No |
P006 | 10.8 | 10.0 | 9.1 | −1.7 | No |
P007 | 8.3 | 7.6 | 7.0 | −1.3 | No |
P008 | 9.9 | 9.2 | 8.3 | −1.6 | No |
P009 | 8.9 | 8.3 | 7.5 | −1.4 | No |
P010 | 11.4 | 10.7 | 9.6 | −1.8 | No |
P011 | 8.5 | 7.9 | 7.1 | −1.4 | No |
P012 | 10.6 | 9.8 | 8.9 | −1.7 | No |
P013 | 9.7 | 9.0 | 8.2 | −1.5 | No |
P014 | 10.9 | 10.2 | 9.3 | −1.6 | No |
P015 | 8.2 | 7.5 | 6.9 | −1.3 | Yes |
P016 | 9.3 | 8.6 | 7.8 | −1.5 | No |
P017 | 10.1 | 9.4 | 8.5 | −1.6 | No |
P018 | 11.7 | 10.9 | 9.8 | −1.9 | No |
P019 | 7.8 | 7.2 | 6.7 | −1.1 | Yes |
P020 | 9.6 | 8.9 | 8.0 | −1.6 | No |
Note. HbA1c values (%) were obtained from laboratory results integrated into the clinic EHR at Baseline (Week 1), Week 4, and Week 8. Change score reflects Week 8 HbA1c minus Baseline HbA1c. Target achievement was defined as HbA1c < 7% per ADA Standards of Care. HbA1c = hemoglobin A1c; ADA = American Diabetes Association.
Table 3
Follow-Up Adherence and Visit Completion Data (N = 20)
Participant ID | Scheduled Visits (n = 6) | Completed Visits (n) | Missed Visits (n) | Telehealth Visits Used | Completion Rate (%) |
P001 | 6 | 6 | 0 | 1 | 100 |
P002 | 6 | 5 | 1 | 0 | 83 |
P003 | 6 | 6 | 0 | 2 | 100 |
P004 | 6 | 4 | 2 | 1 | 67 |
P005 | 6 | 6 | 0 | 0 | 100 |
P006 | 6 | 5 | 1 | 2 | 83 |
P007 | 6 | 6 | 0 | 1 | 100 |
P008 | 6 | 6 | 0 | 0 | 100 |
P009 | 6 | 5 | 1 | 1 | 83 |
P010 | 6 | 4 | 2 | 2 | 67 |
P011 | 6 | 6 | 0 | 0 | 100 |
P012 | 6 | 6 | 0 | 1 | 100 |
P013 | 6 | 5 | 1 | 0 | 83 |
P014 | 6 | 6 | 0 | 2 | 100 |
P015 | 6 | 6 | 0 | 0 | 100 |
P016 | 6 | 5 | 1 | 1 | 83 |
P017 | 6 | 6 | 0 | 1 | 100 |
P018 | 6 | 4 | 2 | 2 | 67 |
P019 | 6 | 6 | 0 | 0 | 100 |
P020 | 6 | 5 | 1 | 1 | 83 |
Note. Biweekly follow-up visits were scheduled over the 8-week implementation period (6 visits per patient). Telehealth visits were offered to patients with mobility or transportation barriers. Completion rate = (completed visits / 6) x 100.
Table 4
Nursing Staff Competency Assessment Results (N = 8)
Staff ID | Role | Pre-Training Score (/100) | Post-Training Score (/100) | Score Change | Threshold Met (>=80%) | Checklist Completion (%) |
S001 | Nurse Practitioner | 62 | 88 | +26 | Yes | 95 |
S002 | Nurse Practitioner | 58 | 84 | +26 | Yes | 92 |
S003 | Nurse Practitioner | 65 | 91 | +26 | Yes | 98 |
S004 | Medical Assistant | 50 | 78 | +28 | No | 85 |
S005 | Medical Assistant | 55 | 83 | +28 | Yes | 88 |
S006 | Care Coordinator | 60 | 86 | +26 | Yes | 94 |
S007 | Health Educator | 70 | 93 | +23 | Yes | 97 |
S008 | Medical Assistant | 52 | 80 | +28 | Yes | 89 |
Note. Pre-training and post-training scores were obtained from the validated diabetes management competency assessment instrument administered at Week 1 and Week 8. The pre-defined competency success criterion was a score >= 80%. Checklist completion reflects the percentage of randomly audited patient visits with complete fidelity documentation.
Table 5
Self-Management Behavior Checklist — Week 8 (N = 20)
Participant ID | Blood Glucose Monitoring (Daily) | Medication Adherence (Self-Report) | Diet/Nutrition Log Completed | Physical Activity Goal Met | Engagement Score (/10) |
P001 | Yes | Yes | Yes | Partial | 8 |
P002 | Partial | Yes | No | No | 5 |
P003 | Yes | Yes | Yes | Yes | 9 |
P004 | No | Partial | No | No | 4 |
P005 | Yes | Yes | Yes | Yes | 10 |
P006 | Partial | Yes | Yes | Partial | 7 |
P007 | Yes | Yes | Yes | Yes | 10 |
P008 | Yes | Yes | Partial | Yes | 8 |
P009 | Yes | Yes | Yes | Partial | 8 |
P010 | No | Partial | No | No | 3 |
P011 | Yes | Yes | Yes | Yes | 9 |
P012 | Yes | Yes | Yes | Partial | 8 |
P013 | Partial | Yes | Partial | Yes | 7 |
P014 | Partial | Yes | Yes | Partial | 7 |
P015 | Yes | Yes | Yes | Yes | 10 |
P016 | Yes | Yes | Yes | Yes | 9 |
P017 | Partial | Partial | Yes | No | 6 |
P018 | No | Partial | No | No | 3 |
P019 | Yes | Yes | Yes | Yes | 10 |
P020 | Yes | Yes | Yes | Partial | 8 |
Note. Self-management behaviors were self-reported by patients at the Week 8 follow-up visit using the standardized self-management checklist. Engagement score was assigned by nursing staff on a 10-point scale based on patient participation, responsiveness, and adherence across the 8 weeks. Partial = behavior was sometimes but not consistently performed.
Table 6
Summary Statistics: Project Implementation Outcomes
Metric | Value |
Total patients enrolled (N) | 20 |
Mean baseline HbA1c (%) | 9.95 |
Mean Week 8 HbA1c (%) | 8.22 |
Mean HbA1c reduction | −1.52% |
Patients achieving HbA1c < 7% at Week 8, n (%) | 2 (10%) |
Overall follow-up completion rate | 89.2% |
Staff achieving >= 80% competency threshold, n (%) | 7 (87.5%) |
Mean staff pre-training score | 59.0 |
Mean staff post-training score | 85.4 |
Patients reporting full medication adherence, n (%) | 14 (70%) |
Patients with complete blood glucose monitoring, n (%) | 13 (65%) |
Note. Summary statistics were calculated from EHR data, competency assessments, and patient self-management checklists collected across the 8-week implementation period. HbA1c = hemoglobin A1c; T2DM = type 2 diabetes mellitus.
Best Capella Professors To Choose From For NURS-FPX9030 Class
- Nicole Aclin, DNP, RN, CNE.
- Adriane Stasurak, DNP, RN, ANP-BC.
(FAQs) related to
NURS FPX 9030 Assessment 2
Question 1: What is NURS FPX 9030 Assessment 2 about?
Answer 1: It analyzes QI project data evaluating ADA protocol’s impact on diabetic patients’ glycemic outcomes.
Question 2: Where can I get expert help with NURS FPX 9030 Assessment 2?
Answer 2: Get expert guidance for NURS FPX 9030 Assessment 2 by visiting TutorsAcademy.co.
Do you need a tutor to help with this paper for you within 24 hours
- 0% Plagiarised
- 0% AI
- Distinguish grades guarantee
- 24 hour delivery
← Previous Assessment: NURS FPX 9030 Assessment 1 | Next Assessment: NURS FPX 9030 Assessment 3 →

